bosutinib

It is used to treat adults and children (from 6 years of age and older) suffering from a type of leukemia called Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia, in chronic, accelerated, or blast phase, when previous treatments have not been effective or adequate.

Form: tablets, film-coated

ATC: L01EA04

Manufacturer: PFIZER EUROPE MA EEIG

This medicine is used to treat adults with a type of blood cancer called Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia, either in newly diagnosed cases or when previous treatments have not been effective or adequate.

Form: tablets, film-coated

ATC: L01EA04

Manufacturer: EG S.P.A.

It is used to treat adults and children aged 6 years and older suffering from a type of leukemia called Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia. It is indicated for newly diagnosed patients or for those who have already received other treatments that have not been effective or adequate.

Form: tablets, film-coated

ATC: L01EA04

Manufacturer: SANDOZ S.P.A.

It is used to treat adults with a type of blood cancer called Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia, both in newly diagnosed cases and when previous treatments have not been effective or adequate.

Form: tablets, film-coated

ATC: L01EA04

Manufacturer: TEVA ITALIA S.R.L.

It is used to treat adults with a type of blood cancer called Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia, either in newly diagnosed cases or when previous treatments have not been effective or adequate.

Form: tablets, film-coated

ATC: L01EA04

Manufacturer: ZENTIVA ITALIA S.R.L.